Prescription Drug Prices

Prescription Drug Prices Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Prescription Drug Prices book. This book definitely worth reading, it is an incredibly well-written.

Making Medicines Affordable

Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,Committee on Ensuring Patient Access to Affordable Drug Therapies
Publisher : National Academies Press
Page : 235 pages
File Size : 54,6 Mb
Release : 2018-03-01
Category : Medical
ISBN : 9780309468084

Get Book

Making Medicines Affordable by National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Care Services,Committee on Ensuring Patient Access to Affordable Drug Therapies Pdf

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

The Right Price

Author : Peter J. Neumann,Joshua T. Cohen,Daniel A. Ollendorf
Publisher : Oxford University Press
Page : 273 pages
File Size : 55,7 Mb
Release : 2021
Category : Business & Economics
ISBN : 9780197512883

Get Book

The Right Price by Peter J. Neumann,Joshua T. Cohen,Daniel A. Ollendorf Pdf

The prescription drug market -- Proposed solutions for rising drug prices -- Measuring the value of prescription drugs -- Measuring drug value : whose job is it anyway? -- Institute for Clinical and Economic Review (ICER) -- Other US value assessment frameworks -- Do drugs for special populations warrant higher prices? -- Improving value measurement -- Aligning prices with value -- The path forward.

Prescription Drug Prices

Author : United States. General Accounting Office
Publisher : Unknown
Page : 32 pages
File Size : 43,8 Mb
Release : 1993
Category : Drugs
ISBN : UOM:39015051985086

Get Book

Prescription Drug Prices by United States. General Accounting Office Pdf

Prescription Drug Pricing: Background, Discount Programs and Cost Lowering Strategies

Author : Elias B. Toft
Publisher : Nova Snova
Page : 248 pages
File Size : 42,5 Mb
Release : 2020-03-13
Category : Electronic
ISBN : 1536176680

Get Book

Prescription Drug Pricing: Background, Discount Programs and Cost Lowering Strategies by Elias B. Toft Pdf

Chapter 1 examines the actions of drug companies in raising prescription drug prices in the United States, as well as the effects of these actions on the Federal and state budgets, and on American families. Chapter 2 addresses frequently asked questions about government and private-sector policies that affect drug prices and availability. Among the prescription drug topics covered are federally funded research and development, regulation of direct-to-consumer advertising, legal restrictions on reimportation, and federal price negotiation. The 340B Drug Pricing Program requires drug manufacturers to sell outpatient drugs at discounted prices to covered entitiesâeligible clinics, hospitals, and othersâin order to have their drugs covered by Medicaid. Covered entities are only allowed to provide 340B drugs to certain eligible patients. Chapter 3 reviews the Health Resources and Services Administration's (HRSA) oversight of the 340B Program to ensure compliance with program rules. In 2017, nearly 60% of U.S. adults aged 18â64 reported being prescribed medication in the past 12 months. Approximately 70% of prescription medications carry out-of-pocket costs. Strategies to reduce prescription drug costs at the individual level are discussed in chapters 4 and 5. Each year, Americans pay more for prescription drugs, and rising drug prices have a disproportionate impact on older Americans. Chapter 6 examines the history of rising drug prices for the brand-name drugs most commonly prescribed for seniors. Generic drugsâcopies of brand-name drugsâlead to significant cost savings. Before a generic drug can be marketed, FDA must approve the generic drug application. According to FDA, applications go through an average of three cycles of review before being approved, which may take years. Chapter 7 examines 1) the first review cycle approval rate of generic drug applications in recent years and factors that may have contributed to whether applications were approved; and 2) changes FDA has made to increase the first review cycle approval rate.

Drugs, Money, and Secret Handshakes

Author : Robin Feldman
Publisher : Cambridge University Press
Page : 203 pages
File Size : 48,9 Mb
Release : 2023-10-31
Category : Law
ISBN : 9781009432948

Get Book

Drugs, Money, and Secret Handshakes by Robin Feldman Pdf

Examines the pharmaceutical industry to expose how higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines.

Prescription Drug Pricing

Author : Jonathan R. Dickson,Amy M. Woebler
Publisher : Unknown
Page : 0 pages
File Size : 44,6 Mb
Release : 2011
Category : Medical economics
ISBN : 1613246390

Get Book

Prescription Drug Pricing by Jonathan R. Dickson,Amy M. Woebler Pdf

The growing cost of brand-name prescription drugs can be a burden on patients, payers and providers of health care, particularly when price increases are large and occur suddenly. Controlling rising prescription drug prices helps to ensure that patients can afford medically necessary and sometimes life-saving medication, and to moderate costs for hospitals and third-party payers such as insurance plans and state and federal governments. This book examines prescription drug pricing costs and control concerns with a focus on extraordinary price increases for brand-name prescription drugs, as well as the characteristics and factors that contributed to this price increase.

Prescription Drug Prices

Author : United States. Federal Trade Commission. Seattle Regional Office
Publisher : Unknown
Page : 40 pages
File Size : 54,6 Mb
Release : 1974
Category : Drugs
ISBN : UIUC:30112079699291

Get Book

Prescription Drug Prices by United States. Federal Trade Commission. Seattle Regional Office Pdf

Prescription Drugs for Half Price or Less

Author : Stephen Hyde
Publisher : Bantam
Page : 177 pages
File Size : 55,5 Mb
Release : 2009-10-07
Category : Reference
ISBN : 9780307480903

Get Book

Prescription Drugs for Half Price or Less by Stephen Hyde Pdf

If you want to save up to 50, 70, even 90% on your prescription drug costs, this is the book you need. Stephen S. S. Hyde, founder of Hyde Rx Services Corporation, is the leading authority on low-cost prescription drug benefits, and now he’s offering individual consumers the expertise he provides to America’s employers and health plans. With the simple, cost-saving techniques outlined in this revolutionary book, you can save literally hundreds, even thousands of dollars on your family’s prescription medications. You’ll discover: • The seven questions you should ask your doctor before he writes a prescription • How your pharmacist can save you money • How to get FREE prescription drugs • How to save on generic, over-the-counter, and brand-name drugs • How to get the lowest prices from retail, mail-order, online, and Canadian pharmacies • How you may be eligible for discount cards and other assistance programs • A Special Seniors Medicare Drug Benefit Report, and much more! With an appendix of directories, pharmacies, and websites to get you started, this book will pay for itself with your very first prescription!

Prescription Drug Prices in Canada and the United States

Author : John Russell Graham,Fraser Institute (Vancouver, B.C.)
Publisher : Unknown
Page : 35 pages
File Size : 55,7 Mb
Release : 2003
Category : Drugs
ISBN : OCLC:54998306

Get Book

Prescription Drug Prices in Canada and the United States by John Russell Graham,Fraser Institute (Vancouver, B.C.) Pdf

In the last couple of years, a grey market has risen between Canada and the United States: the illegal diversion of prescription drugs meant for Canadian patients to medically uninsured Americans who want prescriptions at Canadian prices, which are often much lower than those in the United States. Although sales are currently only about US $650 million, a drop in the bucket of America's huge prescription-drug market, this growing business has drawn criticism from physicians, pharmacists, community pharmacies, and research-based drug manufacturers, and attention from legislators and regulators. On the other hand, a growing number of American patients are taking advantage of Canadian cross-border mail-order pharmacies to save money on their life-saving prescriptions.

Comparative Pricing of Prescription Drugs Sold in the United States and Canada and the Effects on U.S. Consumers

Author : United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism
Publisher : Unknown
Page : 96 pages
File Size : 50,6 Mb
Release : 2003
Category : Consumer protection
ISBN : UOM:39015090410948

Get Book

Comparative Pricing of Prescription Drugs Sold in the United States and Canada and the Effects on U.S. Consumers by United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism Pdf

The Role of NIH in Drug Development Innovation and Its Impact on Patient Access

Author : National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Board on Health Care Services
Publisher : National Academies Press
Page : 103 pages
File Size : 48,5 Mb
Release : 2020-01-27
Category : Medical
ISBN : 9780309498517

Get Book

The Role of NIH in Drug Development Innovation and Its Impact on Patient Access by National Academies of Sciences, Engineering, and Medicine,Health and Medicine Division,Board on Health Sciences Policy,Board on Health Care Services Pdf

To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.

Prescription Drug Prices in Canada and Abroad

Author : Gordon, John R. M,C. J. (Christopher John) Maule,Queen's University (Kingston, Ont.). School of Business
Publisher : Kingston, Ont. : School of Business, Queen ́s University
Page : 15 pages
File Size : 48,5 Mb
Release : 1988
Category : Electronic
ISBN : OCLC:28500962

Get Book

Prescription Drug Prices in Canada and Abroad by Gordon, John R. M,C. J. (Christopher John) Maule,Queen's University (Kingston, Ont.). School of Business Pdf

Reasonable Rx

Author : Stan Finkelstein,Peter Temin
Publisher : FT Press
Page : 207 pages
File Size : 51,8 Mb
Release : 2008-01-23
Category : Business & Economics
ISBN : 9780132703994

Get Book

Reasonable Rx by Stan Finkelstein,Peter Temin Pdf

A Real Plan for Making Drugs Affordable–and Promoting Innovation, Too “This book is a necessity for understanding the pharmaceutical industry. Both the pluses and minuses of the present system are set forth with a judicious combination of historical narrative, economic analysis, and statistical data. The highly original proposals for reform will be a major stimulant to analysis and policy-making.” –Kenneth Arrow, Nobel Laureate in Economics, Professor Emeritus, Stanford University “This is a timely book by authors who know what they are talking about. They tackle a big problem: rising drug prices that are threatening to overwhelm us all–and especially those with limited or absent health care insurance. Will we drive people overseas for healthcare? Will there be social unrest? This book describes the problem and then offers a solution. Worth a careful read by everyone, pharmaceutical manufacturers and government policymakers especially.” –Roger Williams, M.D., Chief Executive Officer of the United States Pharmacopeia and a former senior official of the Food and Drug Administration “This book confounds two sets of skeptics: Those who say there’s no way to resolve the conflict between the need to fund pharmaceutical research and our desire to keep medicine affordable; and those who think that economics never has anything good to say.” –Honorable Barney Frank, Congressman from Massachusetts “This book comes at the right time and could become the starting point of discussions, which will eventually lead us into new era in the healthcare care industry. It will without a doubt become a must for insiders of the pharma- and biotech industries.” –Dr. Jürgen Drews, retired President of Roche Pharmaceutical Group Global Research Acknowledgments viii About the Authors ix Introduction xi Chapter 1: Drugs and Drug Prices 1 Chapter 2: The American Way to Discover Drugs 21 Chapter 3: The Drug Industry Today 39 Chapter 4: Are Drug Companies Risky? 59 Chapter 5: How Not to Lower Drug Prices 77 Chapter 6: Squandering R & D Resources 103 Chapter 7: How to Lower Drug Prices 129 Appendix: Our Solution in Detail 155 Index 177

The Risks of Prescription Drugs

Author : Donald Light
Publisher : Columbia University Press
Page : 179 pages
File Size : 54,6 Mb
Release : 2010
Category : Business & Economics
ISBN : 9780231146920

Get Book

The Risks of Prescription Drugs by Donald Light Pdf

Raises key questions about topics in the pharmaceutical industry, including how the risks of side effects are weighed, if privatization of that risk is prudent, and the high prices for drugs.

Prescription Drugs

Author : John E. Dicken
Publisher : DIANE Publishing
Page : 28 pages
File Size : 45,9 Mb
Release : 2011-08
Category : Medical
ISBN : 9781437983050

Get Book

Prescription Drugs by John E. Dicken Pdf

Prescription drug spending in the U.S. in 2009 totaled $250 billion, of which $78 billion -- or 31% -- was spent by the fed. gov¿t. Prescription drug spending by the fed. gov¿t., patients, and third-party payers, including employers, is driven by many factors, including the prices paid for drugs. This report: (1) examines U&C price trends for commonly used prescription drugs from 2006 through the first quarter of 2010 and compares these trends to those of other medical consumer goods and services; and (2) examines price trends using drug prices other than U&C. Also provides info. on the extent to which prices for individual brand-name drugs changed over the course of this analysis period. Charts and tables. This is a print on demand report.